Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma. - Wikidata - wikimedia - TriplyDB

Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.

Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.

http://www.wikidata.org/entity/Q37683382

about

Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.

http://www.wikidata.org/entity/Q37683382

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Inactivation of the putative u ...... naplastic large cell lymphoma.

@en

Inactivation of the putative u ...... naplastic large cell lymphoma.

@nl

type

label

Inactivation of the putative u ...... naplastic large cell lymphoma.

@en

Inactivation of the putative u ...... naplastic large cell lymphoma.

@nl

prefLabel

Inactivation of the putative u ...... naplastic large cell lymphoma.

@en

Inactivation of the putative u ...... naplastic large cell lymphoma.

@nl

P1433

Q37683382-67DE2654-22A4-4500-B6B9-8972E202D9F2

P1476

Q37683382-C9DBE27C-A4AD-4B0D-A6D0-1FBB3C6C419E

P2093

Q37683382-080A31B3-FEEE-45E3-98DC-03251F81887F

Q37683382-2E140577-1E87-4312-A212-5C6760DFCB3B

Q37683382-3158DD45-2FD1-44DE-95DD-34E00DF279BE

Q37683382-3B12B3B6-C83F-4C56-A4D6-EAE348BE8C35

Q37683382-53855D11-C4A7-4515-9368-1BA408F71270

Q37683382-6F01B676-9B2E-4CCF-91CB-2068F52D806A

Q37683382-923A33B2-908C-46FE-94DD-C0A7AD00A156

Q37683382-BC323131-803A-4E0D-BA09-D2BCE30253F8

Q37683382-BF54BBBA-07BF-40B3-99F6-AEC70B3BFC19

Q37683382-CBB13237-3678-4403-B267-81FEE50618C6

P2860

Q37683382-05C99E47-E95C-4D92-B7B4-C8559170A48D

Q37683382-06472E05-F244-483A-9F56-6419D1F6D986

Q37683382-1663F3D3-A187-4609-AF76-94434333B486

Q37683382-1C2D3B69-30BF-4F2E-B615-B71ED70397F6

Q37683382-307D4B4E-7A50-4F99-837C-B6C598D8A9B9

Q37683382-32856DDE-26AE-4ECC-8454-9DA3456CA6DB

Q37683382-3ECDBB69-B360-40A7-96E3-0AFCEAE62B57

Q37683382-42C92900-C67C-46FC-BAF9-751CB536F321

Q37683382-42D36D33-5DEC-4F9E-8E55-4B7CFB938A87

Q37683382-49D9F4DC-C0F3-4CF3-B003-D717F0FE9E75

P2888

Q37683382-43AC409A-2BF9-4D51-89C4-9E4A134DF00A

P304

Q37683382-8F2B11DE-97CB-4086-91BE-3E94BEF6806B

P31

Q37683382-7D4517C8-570D-4D31-9836-4D5C4C7D0995

P356

Q37683382-7AFAB547-6309-4B6C-B883-581BD00FF5C1

P433

Q37683382-7CE529B3-7733-4314-B2D7-69B976115B58

P478

Q37683382-C4F002D5-DF92-44C1-8DD5-8C11CF37E6C8

P50

Q37683382-052BEEA4-35A1-4885-80C5-6A06A96C0D1A

Q37683382-4E9686ED-7D14-4365-8771-7D546A447B28

Q37683382-DA396D0E-DB28-41D9-A7AB-9238B0996D86

P577

Q37683382-DA51638E-7304-4E84-AB14-6A15AB7E80C1

P6179

Q37683382-8DEEDFEE-0864-40B2-8675-170EB4CF755F

P698

Q37683382-AB3213CC-76A4-4CC3-828B-E8EB4DCF90D5

P932

Q37683382-0BBD7510-BAAD-4FCF-8E41-4E5B6C01675F

P356

P1433

P1476

Inactivation of the putative u ...... naplastic large cell lymphoma.

@en

P2093

B Dörken

http://www.w3.org/2001/XMLSchema#string

F Hummel

http://www.w3.org/2001/XMLSchema#string

G Lenz

http://www.w3.org/2001/XMLSchema#string

K D Wurster

http://www.w3.org/2001/XMLSchema#string

K Köchert

http://www.w3.org/2001/XMLSchema#string

M Hummel

http://www.w3.org/2001/XMLSchema#string

M Janz

http://www.w3.org/2001/XMLSchema#string

M-L Hansmann

http://www.w3.org/2001/XMLSchema#string

R Siebert

http://www.w3.org/2001/XMLSchema#string

S Hartmann

http://www.w3.org/2001/XMLSchema#string

P2860

Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses Anchorage-independent growth

A system for stable expression of short interfering RNAs in mammalian cells

Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity

Pdlim2, a novel PDZ-LIM domain protein, interacts with alpha-actinins and filamin A

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: cancer and leukemia Group B protocol 50206.

TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma.

DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control.

Epigenetic repression of PDZ-LIM domain-containing protein 2: implications for the biology and treatment of breast cancer.

Molecular karyotypes of Hodgkin and Reed-Sternberg cells at disease onset reveal distinct copy number alterations in chemosensitive versus refractory Hodgkin lymphoma

P2888

P304

602-613

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LEU.2016.238

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Daniel Krappmann

P577

2016-08-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1031492227

http://www.w3.org/2001/XMLSchema#string

P698

27538486

http://www.w3.org/2001/XMLSchema#string

P932

5339435

http://www.w3.org/2001/XMLSchema#string